EDA/Ectodysplasin Antibody (DMC388) - Chimeric
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-48320
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Clonality
Host
Isotype
Description
Scientific Data Images for EDA/Ectodysplasin Antibody (DMC388) - Chimeric
Flow Cytometry: EDA/Ectodysplasin Antibody (DMC388) - Chimeric [NBP3-48320]
Flow cytometry analysis with Anti-EDA/Ectodysplasin/Ectodysplasin (DMC388) on HEK293 cells transfected with human EDA/Ectodysplasin/Ectodysplasin (Blue histogram) or HEK293 transfected with irrelevant protein (Red histogram).Applications for EDA/Ectodysplasin Antibody (DMC388) - Chimeric
Flow Cytometry
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: EDA/Ectodysplasin
Ectodysplasin (EDA) is a type II transmembrane protein belonging to the TNF superfamily. It can be expressed as eight alternatively spliced isoforms that are encoded by the EDA gene. Isoforms of EDA are expressed in cells of ectodermal origin, where they are localized to the cell surface and can be released in a soluble form following cleavage by Furin. The EDA-A1 and EDA-A2 splice variants differ by the deletion of two amino acids in the extracellular domain of EDA-A2. Despite this minor difference, EDA-A1 and EDA-A2 display strong receptor specificity. EDA-A1 binds to EDAR, whereas EDA-A2 binds to XEDAR. EDA-A1 and EDA-A2 are required during development, and loss or mutation of EDA results in abnormal development of hair follicles, sweat glands, and teeth. Mutations in the EDA gene are associated with a group of developmental disorders identified as ectodermal dysplasia type 1.
Alternate Names
Gene Symbol
Additional EDA/Ectodysplasin Products
Product Documents for EDA/Ectodysplasin Antibody (DMC388) - Chimeric
Product Specific Notices for EDA/Ectodysplasin Antibody (DMC388) - Chimeric
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.